11:07 AM EST, 12/10/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were lower late Tuesday morning, declining 0.38% to 1,348.76 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by telecommunications company VEON (VEON) and biopharmaceutical company Cellectis ( CLLS ) , which rose 1.9% and 1.5% respectively. They were followed by medical device maker EDAP (EDAP) and financial services company Banco Santander (SAN), which were up 3.6% and 0.5% respectively.

The decliners from continental Europe were led by biopharmaceutical company DBV Technologies ( DBVT ) and accommodations booking company trivago (TRVG), which fell 5.8% and 4.7% respectively. They were followed by biotech firm Evaxion Biotech ( EVAX ) and internet browser company Opera (OPRA), which lost 4.4% and 3.2% respectively.

From the UK and Ireland, the gainers were led by cruise line operator Carnival (CUK) and software firm Endava ( DAVA ) , which increased 3.4% and 0.5% respectively. They were followed by BP oil and gas company (BP) and financial services company HSBC ( HSBC ) , which rose 0.5% and 0.2% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Akari Therapeutics ( AKTX ) and biotech firm Trinity Biotech ( TRIB ) , which tumbled 16.4% and 13.1% respectively. They were followed by pharmaceutical company Silence Therapeutics ( SLN ) and biopharmaceutical company Bicycle Therapeutics ( BCYC ) , which were down 3.6% and 2.1% respectively.